Skip to main content
HRES 1434 117th Congress House Health Civil actions and liability Department of Justice Family planning and birth control Federal preemption Food and Drug Administration (FDA) Health technology, devices, supplies Licensing and registrations Medical tests and diagnostic methods Sex and reproductive health

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder)…

Show full title

Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

Introduced: October 14, 2022 See on congress.gov
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Agreed to (House)
Dec 21, 2022
Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
Dec 21, 2022
Passed/agreed to in House: Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
Oct 17, 2022
Referred to the Subcommittee on Health.
Oct 14, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 14, 2022
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.

The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.

What's happening now December 21, 2022

Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.

 Related & companion bills 1
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
Cite this page click to expand
APA
U.S. Congress. (2026). H. Res. 1434: Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.. 117th Congress. Open America. https://openamerica.io/bill/117-HRES-1434/
MLA
"H. Res. 1434: Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HRES-1434/.
Bluebook (legal)
H. Res. 1434, 117th Cong. (2026), https://openamerica.io/bill/117-HRES-1434/.
Markdown link
[H. Res. 1434: Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.](https://openamerica.io/bill/117-HRES-1434/)
Report a problem